References
- Specks U, Fervenza FC, McDonald TJ, Hogan MC. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum. 2001;44(12):2836–40.
- Ferraro AJ, Day CJ, Drayson MT, Savage CO. Effective thera-peutic use of rituximab in refractory Wegener's granulomatosis. Nephrol Dial Transplant. 2005;20(3):622–5.
- Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vascu-Ms. Arthritis Rheum. 2005;52(1):262–8.
- Keogh KA, Ytterberg SR, Fervenza FC, Carlson KA, Schroeder DR, Specks U. Rituximab for refractory Wegener's granuloma-tosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006;173(2):180–7.
- Eriksson P. Nine patients with anti-neutrophil cytoplasmic anti-body-positive vasculitis successfully treated with rituximab. J Intern Med. 2005;257(6):540–8.
- Aries PM, Hellmich B, Voswinkel J, Both M, Nolle B, Ho11-Ulrich K, et al. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis. 2006;65(7):853–8.
- Matsudaira R, Tamura N, Nawata M, Kaneda K, Takasaki Y. Successful treatment with rituximab in a refractory Wegener's granulomatosis with hypertrophic pachymeningitis and the right orbital granuloma. Nippon Naika Gakkai Zasshi 2007;96(7):1464–6.
- Minami R, Miyamura T, Watanabe H, Takahama S, Yamamoto M, Suematsu E. Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab. Nihon Rinsho Meneki Gakkai Kaishi. 2007;30(2):133–8.
- Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999;189(10):1639–48.
- Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994;180(4):1295–306.